News > News Archive

2017
  10/12/2017 Scientists Identify the Structure of a Key Enzyme that Protects the Brain Against PD
  10/05/2017 Researchers Develop New Tool to Diagnose First Signs of Parkinson's Disease
  10/03/2017 MSU Researcher Hopes to Link Sense of Smell with Development of PD
  09/13/2017 Asthma Medication May Reduce the Risk of Developing Parkinson’s Disease
  08/18/2017 Telemedicine as Effective as In-person Care for Parkinson's Disease
  08/15/2017 Global Kinetics Corp Secures First US Patent for its Digital Health System
  08/09/2017 PD Movement Lab’s “PD Outliers” Podcast with John Ball
  08/09/2017 LSVT Global Offers Free Educational Seminar for People with Parkinson’s Disease
  08/07/2017 Diabetes Drug Shows Promise Against Parkinson’s Disease
  07/28/2017 The Michael J. Fox Foundation Announces Award to Drive Phase IIa Clinical Trial Investigating Potential Safety and Benefit of Nilotinib in PD
  07/27/2017 Forbes Includes Acadia, Maker of Nuplazid on List of Most Innovative Growth Companies
  07/24/2017 Mitsubishi Buys Israel's NeuroDerm for $1.1B
  07/12/2017 Participants Invited to Take Survey on Vision and Parkinson’s Disease
  07/11/2017 US WorldMeds is Now Distributing XADAGO® (Safinamide) in the U.S. for PD Patients
  07/07/2017 Drug Discovery: Alzheimer's and Parkinson's Spurred by Same Enzyme
  07/07/2017 Global Kinetics Launching Large Randomized Study of Wearable for Parkinson’s Disease
  07/07/2017 Study Suggests CLR01 May Improve Symptoms of Early Parkinson’s
  07/07/2017 Acorda Submits New Drug Application to U.S. Food and Drug Administration for CVT-301
  06/26/2017 Statins May Speed Symptoms of Onset Parkinson's Disease in Some People
  06/22/2017 Autoimmunity May Have Role in Parkinson's Disease
  06/19/2017 Balance and Movement Improved in Animal Model of Parkinson’s Disease
  06/08/2017 Low-fat Dairy Intake May Raise Parkinson's Risk
  06/08/2017 Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study
  06/08/2017 NeuroDerm Presents Six Posters at the 21st International Congress of Parkinson’s Disease and Movement Disorders
  06/06/2017 Tom Isaacs, President of The Cure Parkinson's Trust Has Died
  05/22/2017 Acorda Therapeutics to Present Update on Phase 3 Study of CVT-301 in Parkinson’s Patients
  05/19/2017 Biomarkers for Cognitive Impairment in Parkinson's Disease Revealed
  05/15/2017 Survey Examines Social Support in Parkinson’s Disease from the Patient’s Perspective
  05/15/2017 New App Adjusts Brain Stimulators For Parkinson’s Patients
  05/15/2017 UCB Adds Website for its Facebook-based Parkinson's Community
  05/15/2017 Microsoft's 'Project Emma' is a Wearable for People Living with PD
  05/01/2017 Acorda Expands Alexa Skill Offering for Parkinson’s Awareness Month
  04/20/2017 NeuroDerm to Ring the Nasdaq Stock Market Opening Bell and Participate in the Parkinson’s Unity Walk
  04/20/2017 Medtronic Brain Therapies Sponsors Parkinson’s Unity Walk
  03/29/2017 Acorda Announces Long-Term Safety Data for CVT-301
  03/22/2017 FDA Approves Xadago to Treat Parkinson’s Disease
  03/15/2017 Cancer Drug That Might Slow Parkinson's and Alzheimer's Headed for Bigger Tests
  03/03/2017 Study Shows Link Between Microbiome in the Gut and Parkinson's Disease
  03/01/2017 Researchers Suggest New Theory for How Parkinson's Disease Develops
  02/20/2017 Researchers Discover Genetic Switch for Parkinson’s Disease
  02/15/2017 US WorldMeds is Funding Clinical Trial Studying Effectiveness of New Infusion Therapy to Help Smooth Out Movement for Patients with PD
  02/09/2017 Acorda Announces Positive Phase 3 Clinical Trial Results for CVT-301
  02/09/2017 Blood Test Might Make Parkinson's Diagnosis Easier
  02/01/2017 Tell Congress How You May Be Impacted by Health Care Policy Changes
  01/31/2017 LSVT BIG Seminar on Sunday, February 5, 2017 in West Orange, NJ
  01/26/2017 The Parkinson’s Institute and Clinical Center Awarded $1.9 Million from California Institute for Regenerative Medicine
  01/12/2017 CurePSP 2017 Southwest Family Conference to be Held in Phoenix on March 17-18, 2017
  01/06/2017 Adamas Announces US FDA Acceptance of ADS-5102 New Drug Application for the Treatment of Levodopa-induced Dyskinesia in Patients with PD
  01/03/2017 Single Protein May Hold Secret to Treating Parkinson’s Disease

Go to earlier archived stories